Rabbit's Cervical Tracheal Replacement with Cryopreserved Homograft: Effects on the Viability and Rejection.
- Author:
Tae Hee WON
1
;
Jung Wook SUH
;
Sook Whan SUNG
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Ewha Womans University, Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Cryopreservation;
Trachea;
transplantation;
Transplantation;
homologous;
Rejection
- MeSH:
Allografts*;
Autografts;
Cartilage;
Cryopreservation;
Epithelial Cells;
Epithelium;
Nitrogen;
Rabbits;
Regeneration;
Trachea;
Transplantation
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
1998;31(12):1127-1133
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: There are no ideal substitutes for tracheal replacement. Therefore we investigated the possibility of clinical use of cryopreserved tracheal homograft with special interest in the viability and rejection of the epithelial cell and cartilage. MATERIAL AND METHOD: Rabbit's trachea was sected and stored in liquid nitrogen tank for 1 month. Tracheal replacement was done in 45 rabbits with autograft (n=15, Group 1), fresh allograft (n=15, Group 2) and cryopreserved homograft (n=15, Group 3). After 7, 14, and 30 days, 5 rabbits in each group were sacrificed and the regeneration of epithelium and cartilage and the degree of rejection were assessed by counting the monocellular infiltration. RESULT: Investigation at day 7, showed no difference in epithelial regeneration, however, at days 14 and 30, Group 1 showed better regeneration of epithelium than groups 2 and 3. There was no difference of epithelial regeneration between group 2 and 3. There was little rejection at day 7, but at days 14 and 30, there was significant rejection in group 2 and group 3. (p<0.05). Group 3 showed lesser rejection than group 2 at days 14 and 30, but it was not statistically significant. Cartilage showed no rejection and maintained its viability in groups 2 and 3. CONCLUSION: Cryopreserved tracheal homograft can maintain its viability, therefore it may represent a possibility of clinical application for tracheal replacement. However, cryopreservation can not eliminate the antigenicity of the trachea completely. Furthere studies for lowering the antigenicity and rejection should be performed for an ideal substitute for tracheal replacement.
